|1.||Yang, Qingang: 2 articles (10/2008 - 06/2005)|
|2.||Chen, Lili: 2 articles (10/2008 - 06/2005)|
|3.||Shen, Xu: 2 articles (10/2008 - 06/2005)|
|4.||Bai, Donglu: 2 articles (10/2008 - 06/2005)|
|5.||George, F R: 2 articles (04/2000 - 04/2000)|
|6.||Ritz, M C: 2 articles (04/2000 - 04/2000)|
|7.||O'Dell, L E: 2 articles (04/2000 - 04/2000)|
|8.||Kremer, Thomas: 1 article (09/2013)|
|9.||Kneser, Ulrich: 1 article (09/2013)|
|10.||Hernekamp, Jochen-Frederick: 1 article (09/2013)|
05/01/1995 - "Thus, cinanserin appears to exert profound protective effects in two models of effort-induced ischemia."
05/01/1995 - "After infusion of 20 micrograms/kg/min cinanserin (intracoronary, i.c.), ST segment elevation was significantly reduced during pacing-induced ischemia at all times measured postdrug. "
05/01/1995 - "We therefore determined if the 5HT2 antagonist cinanserin can protect the ischemic myocardium in two models of pacing-induced ischemia in anesthetized dogs. "
04/01/1984 - "BOL and cinanserin treatment 5 minutes after the onset of ischemia was beneficial because neurologic improvement was permanent, and pretreatment with these drugs also markedly reduced damage. "
10/01/1993 - "We determined the effect of the 5-HT2 receptor antagonists cinanserin (0.1-10 microM), ketanserin (0.3-10 microM), and LY 53857 (1-10 microM) on time to contracture, recovery of contractile function, and lactate dehydrogenase (LDH) release after 25-min global ischemia and 30-min reperfusion in isolated rat heart. "
04/28/2000 - "In addition, cinanserin attenuated convulsions more potently in 6J relative to 6ByJ mice. "
04/28/2000 - "Experiment 2 compared 5-HT(2) receptor densities across these mice and cocaine-induced convulsions following pretreatment with the 5-HT(2) antagonist cinanserin. "
04/01/2000 - "The role of 5-HT in mediating this toxic effect of cocaine appears to be due to activation of 5-HT(2) receptors, because cocaine-induced convulsions are blocked by the 5-HT(2) antagonists cinanserin, ketanserin, and pirenperone. "
01/01/1987 - "The 5-hydroxytryptamine (5-HT) receptor antagonists, mianserin, methergoline, cinanserin and methysergide antagonised the 5-MeODMT (0.5 to 4.0 mg/kg) induced prolongations of latency to onset of convulsions substantially and to a lesser extent the prolongation of duration. "
02/01/1997 - "The 5-HT reuptake inhibitor fluoxetine enhanced the occurrence and severity of convulsions produced by 100 mg/kg (-) cocaine, while the 5-HT2 receptor antagonists cinanserin, ketanserin and pirenperone antagonized cocaine-induced convulsions in a dose-dependent manner. "
|3.||Myoclonus (Nocturnal Myoclonus)
01/01/1986 - "S2 antagonists inhibited limb (arrhythmic and asynchronous) and axial (truncal) myoclonus in a dose-dependent manner in the rank order of potency: pirenperone greater than pipamperone greater than ketanserin = cinanserin. "
01/01/1986 - "5-HT antagonists (methergoline, methysergide, and cinanserin) did not potentiate myoclonus induced by p,p'-DDT. "
05/01/1985 - "Antagonists of 5-HT (methergoline, methysergide and cinanserin) did not potentiate the myoclonus induced by p,p'-DDT. "
12/01/1982 - "The myoclonus induced by tryptamine (40 mg/kg) plus pargyline (75 mg/kg) was differentially inhibited by the indoleamine receptor antagonists, methergoline (5 mg/kg) which was more potent than methysergide (10 mg/kg), mianserin (10 mg/kg) which was more potent that cyproheptadine (10 mg/kg) and propranolol (20 mg/kg) which was more potent than cinanserin (10 mg/kg). "
11/21/1975 - "Cinanserin attenuated the effects of all doses of DOM and those of higher doses of amphetamine on shock avoidance. "
11/01/1985 - "Metergoline (0.03-1.0 mg/kg), cyproheptadine (0.1-1.0 mg/kg) and cinanserin (1.0-10 mg/kg) produced dose-related increases in responding maintained by food, whereas only metergoline and methysergide increased behavior maintained by shock presentation. "
07/01/1985 - "Intramuscular administration of metergoline (0.03-0.3 mg/kg), methysergide (0.1-1.0 mg/kg), cyproheptadine (0.1-1.0 mg/kg), mianserin (0.1-10 mg/kg) and cinanserin (1.0-3.0 mg/kg) increased punished responding under the stimulus-shock termination and food schedules. "
11/01/1985 - "The behavioral effects of the serotonin (5-HT) precursor l-5-hydroxytryptophan (l-5-HTP) and the phenylpiperazine 5-HT agonists 6-chloro-2-(1-piperazinyl)pyrazine (MK-212), 1-(m-trifluromethylphenyl) piperazine (TFMPP), 1-(m-chlorophenyl)piperazine (CPP) and 2-(1-piperazinyl)quinoline (quipazine) were compared with those of the putative 5-HT antagonists metergoline, methysergide, cyproheptadine, cinanserin and ketanserin under a multiple 5-min fixed-interval schedule of food or electric shock presentation in squirrel monkeys. "
10/01/1973 - "The reduction in brain NA was not prevented except at the 18 h time interval.4. An injection of 1 mg/kg Delta(9)-THC intravenously into rats 3 h after an intraperitoneal injection of reserpine accentuated the reserpine hypothermia as well as the reduction of 5-HT but not of NA in the brain.5. The reserpine hypothermia was not prevented by a single intravenous injection of 1 mg/kg Delta(9)-THC when cinanserin, a 5-HT inhibitor, was injected 30 min before the reserpine."
01/01/1981 - "The hypothermia was blocked by 5-HT antagonists with a relative potency of methiothepin greater than methergoline greater than methysergide greater than cinanserin greater than cyproheptadine. "
11/01/1983 - "However, it caused hyperthermia in rats pretreated with the DA antagonist, haloperidol, and hypothermia in rats pretreated with the serotonin depletor, p-chlorophenylalanine or serotonin antagonists, cyproheptadine, metergoline or cinanserin. "
|3.||Serotonin (5 Hydroxytryptamine)
|7.||Cocaine (Cocaine HCl)